Thermo Fisher Scientific Inc. (TMO) Financials

TMO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 113.3 billion 61.3 billion
Dec. 31, 2025 110.3 billion 56.8 billion
Sept. 30, 2025 103.0 billion 52.0 billion
June 30, 2025 101.2 billion 50.6 billion

TMO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 816.0 million 83.0 million
Dec. 31, 2025 3.0 billion 84.0 million
Sept. 30, 2025 1.8 billion 70.0 million
June 30, 2025 1.1 billion 81.0 million

TMO Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 1.7 billion
Dec. 31, 2025 2.0 billion
Sept. 30, 2025 1.6 billion
June 30, 2025 1.6 billion

TMO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 3.3 billion 40.1 billion -
Dec. 31, 2025 10.1 billion 35.9 billion 1.2 billion
Sept. 30, 2025 3.5 billion 31.9 billion -
June 30, 2025 6.4 billion 33.0 billion -

TMO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 373.0 million
Dec. 31, 2025 377.0 million
Sept. 30, 2025 378.0 million
June 30, 2025 378.0 million

TMO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 376.0 million 336.0 million 1.8 billion -
Dec. 31, 2025 465.0 million 357.0 million 2.0 billion -
Sept. 30, 2025 404.0 million 347.0 million 2.4 billion -
June 30, 2025 294.0 million 352.0 million 1.8 billion -

TMO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 11.0 billion 6.5 billion
Dec. 31, 2025 12.2 billion 7.6 billion
Sept. 30, 2025 11.1 billion 6.5 billion
June 30, 2025 10.9 billion 6.8 billion

TMO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TMO

List: Challengers

Price: $526.46

52 week price:
403.36
643.99

Dividend Yield: 0.35%

5-year range yield:
0.17%
0.44%

Forward Dividend Yield: 0.36%

Payout Ratio: 9.69%

Payout Ratio Range:
-6393.56%
562.54%

Dividend Per Share: 1.88 USD

Earnings Per Share: 18.20 USD

P/E Ratio: 25.65

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 1.2 million

Ebitda: 1.6 billion

Market Capitalization: 192.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 15

DGR3: 13.58%

DGR5: 14.89%

DGR10: 10.75%

Links: